Articles tagged with Rheumatism
Dr Germain Honvo, a young investigator, receives the prestigious award for his international contributions to osteoarthritis research and publications on guideline development. He is recognized as a future thought leader in the musculoskeletal field.
The IOF Medal of Achievement is awarded to individuals who significantly advance osteoporosis research and increase awareness of the disease. Professor Jean-Yves Reginster has made major impacts on the field through his original scientific contributions, education, and advocacy.
Bernard Cortet receives ESCEO-IOF Herbert Fleisch Medal for groundbreaking contributions to osteoporosis research, including publications on clinical recommendations and patient outcomes. He is recognized for his leadership roles in French Society of Rheumatology and Osteoporosis Research and Information Group.
Professor Osvaldo Daniel Messina was awarded the 2023 IOF CNS Medal for his significant contributions to osteoporosis prevention. He has expanded IOF's messages and outreach in Argentina and internationally, promoting fracture prevention and healthy mobility.
The IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases is the largest international scientific event devoted to musculoskeletal disorders. The congress presents new clinical advances and research on osteoporosis, osteoarthritis, sarcopenia, frailty, and rare skeletal disorders.
A new study from Lund University estimates that regression to the mean can account for up to 1 point improvement in pain scores among osteoarthritis patients. This natural phenomenon can lead to false positives in clinical trials, masking the true efficacy of treatments.
Rheumatologists are crucial in detecting neurologic Lyme disease due to its broad spectrum of symptoms and signs. Early treatment has a favorable prognosis, but delayed diagnosis can lead to severe symptoms.
Researchers find that patients with destructive nasal lesions may be suffering from cocaine-induced granulomatosis with polyangiitis, a condition often misdiagnosed. Cocaine use can trigger production of antibodies leading to symptoms similar to idiopathic Granulomatosis With Polyangiitis.
The new EULAR points-to-consider support individuals with rheumatic and musculoskeletal diseases (RMDs) by acknowledging the benefits of staying in work, including increased self-worth and financial independence. These principles aim to optimise work-life balance and support physical and mental health.
A large randomized clinical trial demonstrated Octagam 10% as an efficacious and well-tolerated treatment option for adult dermatomyositis patients. The study showed improved outcomes in patients with this rare disease, providing a much-needed treatment alternative.
A collaborative network led by Cincinnati Children's Hospital Medical Center has received an $8 million grant to identify and validate biomarkers for acute rheumatic fever. This will enable the development of a sensitive and specific diagnostic test, crucial for diagnosing rheumatic heart disease, which is caused by a slow but progress...
The Brigham and Women's Hospital will implement and evaluate an integrated service delivery model (PEN-Plus) for severe chronic noncommunicable diseases, such as type 1 diabetes and rheumatic heart disease, in eight low- and lower-middle-income countries. The initiative aims to enable one million of the world's poorest children and you...
The International Osteoporosis Foundation proposes a screening strategy to identify women at high risk of hip fracture, which could lead to a reduction in treatment gaps and improved identification of fractures. The approach combines low-cost assessment with targeted intervention using low-cost generic treatments.
Researchers developed new method to visualize CNS fibroblasts and their intercellular interactions in the CNS. The technique provides a detailed picture of CNS fibroblasts, including their location, size, morphology, and gene/protein expression patterns.
Dr Nicholas Fuggle, a UK researcher, has been awarded the prestigious ESCEO-IOF Pierre Meunier Young Scientist Award for his significant contributions to research in musculoskeletal ageing. He is recognized for his work on determinants of musculoskeletal ageing and digital healthcare.
Professor Antonio Cherubini has made significant contributions to the field of geriatric medicine and musculoskeletal diseases. He is recognized for his work on aging, bone health, and age-related diseases.
The Virtual WCO-IOF-ESCEO 2022 Congress will feature leading experts on osteoporosis, osteoarthritis, and musculoskeletal diseases, with a focus on new clinical research and advances in prevention and patient care. Prestigious awards will also be presented.
The International Osteoporosis Foundation awarded Professor Thierry Thomas the IOF Committee of Scientific Advisors (CSA) Medal of Achievement for his outstanding scientific contributions to osteoporosis. The award recognizes his work on secondary fracture prevention and post-fracture care coordination programs.
The World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO) 2022 will discuss secondary fracture prevention. Global experts will provide clinical guidance and information on post-fracture care through various sessions.
Researchers aim to determine if knee structure changes predict clinical outcomes in people with osteoarthritis. The study will examine 76,000 X-rays and clinical data from diverse cohorts to establish healthy knee structure ranges.
Researchers confirm that skin infections, not just throat infections, trigger acute rheumatic fever, with Māori and Pacific children at highest risk. The study's findings have huge implications for prevention, suggesting a new focus on addressing skin infections to reduce the risk of rheumatic fever in New Zealand and internationally.
A recent study identified several protein biomarkers that protect against the development of inflammatory diseases such as psoriasis and osteoarthritis. The researchers used Mendelian Randomization to determine whether high levels of these proteins are associated with a lower risk of disease.
Researchers at UToledo have developed a protein-based vaccine that promotes a strong immune response, effectively treating rheumatoid arthritis and improving bone quality. The findings suggest long-term benefits following immunization.
Researchers at Mayo Clinic's Center for Individualized Medicine found that the gut microbiome is connected to a patient's outcome in rheumatoid arthritis. By analyzing stool samples from 32 patients with rheumatoid arthritis, they identified several traits of the gut microbiome linked to future prognosis.
A study published in Current Rheumatology Reviews found that rehabilitation exercises significantly improved functional strength and reduced weight in knee osteoarthritis patients. The researchers also noted an increase in exercise adherence among the rehabilitation group compared to the control group.
The HIPGEN study, a multinational trial, investigates the efficacy and safety of allogeneic placenta-expanded adherent stromal cells to improve recovery after hip fracture arthroplasty. The trial aims to combat immobility and associated problems by strengthening periarticular hip musculature.
Researchers found significant alterations in serum amino acid profiles in children with ADHD, including lower levels of histidine, glutamine, and proline, as well as higher levels of aspartic acid and hydroxyproline. These findings may help develop new treatment strategies for the disorder.
Researchers developed an organ-preserving treatment method to repair damaged vein valves, achieving a success rate of 95.24% in eliminating varicose vein problems. The therapy uses a thin sheath around the defective vein to restore its normal diameter and prevent serious health issues.
The Hong Kong Society of Rheumatology has developed consensus recommendations for COVID-19 vaccination in adult patients with autoimmune rheumatic diseases. The guidelines address concerns about vaccine efficacy and safety, as well as considerations for immunosuppressed patients.
A new protocol called Quit Connect has been shown to increase electronic referrals to free, state-run tobacco quitlines among patients with rheumatic diseases. The program, which leverages electronic health record prompts for nurses and medical assistants, resulted in a 71% increase in referrals.
Researchers found that patients with public health insurance, a history of Child Protective Services involvement, and an unscheduled hospitalization during pediatric care were at higher risk for end-stage renal disease and death. Childhood-onset lupus patients face significant challenges as they transition to adult healthcare.
Researchers found that calcium-sensing receptor (CaSR) is expressed in neutrophils, monocytes/macrophages, and T lymphocytes, regulating cytokine secretion, chemotaxis, and ligand delivery. This receptor also contributes to the development of several diseases, including sepsis, cryopyrin-associated periodic syndromes, and rheumatism.
A new study found that people with rare autoimmune rheumatic diseases are at a greater risk of dying during the Covid-19 pandemic, particularly those under 35 and women. The research also revealed that working-age individuals with these conditions face similar mortality rates to someone 20 years older in the general population.
A global survey of 427 children with rheumatic diseases found only 5% developed COVID-19, with none requiring hospitalization or severe complications. The study suggests that children with rheumatic disease should continue their immunosuppressive medications during the pandemic.
The new guideline recommends increased use of biologic drugs, reduced steroid treatment, and regular immunizations for infectious diseases. Disease-modifying treatments are now more rapidly escalated in JIA patients, reducing the need for oral or intravenous steroids.
Studies found Black, Latinx, and Asian patients with rheumatic diseases are more likely to experience severe COVID-19 outcomes. These disparities will worsen existing health issues for patients with rheumatic disease during the pandemic
A large European cross-sectional study found that patients with axial spondyloarthritis experience a significant delay in diagnosis due to misdirected referrals and involvement of multiple medical professionals. The study recommends initiating measures to prevent such delays and facilitate timely referral to a rheumatologist.
The European League Against Rheumatism (EULAR) has launched a Virtual Research Centre to address barriers in rheumatic and musculoskeletal disease research. The centre aims to facilitate collaborative research, provide access to resources and technology, and develop broad coalitions for innovation and training.
A growing number of patients in Europe are taking opioids for pain related to rheumatic and musculoskeletal diseases, with risks of addiction and dependency identified. Experts warn that measures must be taken to use these analgesics more safely.
Doctors propose using antimalarial drugs like chloroquine and hydroxychloroquine to treat Covid-19 patients with pneumonia or as primary prophylaxis for healthy individuals at highest risk. However, limited global supplies may hinder this approach.
Researchers found that psoriasis onset age determines whether arthritis starts first, with a 65-month delay for arthritis onset after psoriasis. Early-onset psoriasis is strongly associated with arthritis onset, suggesting a different subgroup of PsA patients.
A preclinical study shows that IL-6 protects T follicular helper cells from deleterious effects of IL-2 by interrupting a feedback loop, allowing them to receive sustained T-cell receptor stimulation. This finding has important therapeutic implications for autoimmune diseases like lupus and may lead to better treatment options.
The phase 2B study demonstrated superior efficacy of tildrakizumab versus placebo in patients with psoriatic arthritis, achieving high response rates for PASI 90 and ACR 50. The treatment was generally safe, with minor adverse events reported.
A Phase IIa trial found that verinurad with febuxostat significantly reduced urinary albumin-to-creatinine ratio by 39% and serum urate levels by 57% after 12 weeks. The effect was sustained through week 24.
A study of 71 post-menopausal women found that those receiving zoledronate prior to denosumab had significantly lower risk of BMD loss. Younger age and higher bone turnover markers increased the risk of BMD loss after denosumab discontinuation.
A study published in EULAR 2019 found that patients with osteoarthritis who undergo partial knee replacement have a 25-50% lower risk of venous thromboembolism, but an increased risk of revision compared to total knee replacement. The long-term benefits of partial knee replacement are offset by the higher risk of revision.
Researchers have identified two new biomarkers, ApoB:A1 ratio and metabolomic lipoprotein signatures, to predict cardiovascular risk in juvenile-onset systemic lupus erythematosus (JSLE) patients. These biomarkers can help identify high-risk patients and inform tailored disease treatments.
A recent European survey found that gout is being diagnosed late, poorly controlled, and not regularly monitored. Eight out of ten patients are satisfied with their current treatment, indicating low expectations. The study highlights significant gaps in the management of gout, emphasizing the need for improved education and care.
A study found that cyclosporine significantly reduced proteinuria in patients with lupus nephritis, achieving higher remission rates compared to mycophenolate mofetil and azathioprine. After a 10-year follow-up, the majority of patients in the cyclosporine group achieved complete remission.
Ultrasound imaging of carotid arteries reveals clog extent and cardiovascular risk; combining data with traditional risk factors improves prediction accuracy. Early intervention through therapies like lipid lowering can lower cardiovascular event risk in patients with psoriatic disease.
Researchers at NYU Langone Health have found a strong link between systemic lupus erythematosus (SLE) and an abnormal mix of bacteria in the gut. The study showed that patients with SLE had significantly higher levels of Ruminococcus gnavus bacteria in their guts, which triggered immune reactions and disease flares.
A molecular network controlling connective tissue deposition has been decrypted, revealing a key protein PU.1 that causes pathological scarring. Inhibiting PU.1 may provide a new way to treat fibrotic diseases such as systemic sclerosis and idiopathic pulmonary fibrosis.
In connective tissue diseases, excessive activation of connective tissue cells leads to hardening and scarring within organs. The discovery of the protein PU.1 reveals a molecular mechanism responsible for ongoing activation of these cells, leading to fibrotic diseases.
New research reveals a link between immune checkpoint inhibitors and the development of musculoskeletal and rheumatic diseases. The most commonly reported adverse events include arthralgia, myalgia, sicca syndrome, polymyalgia rheumatica, and systemic lupus erythematosus.
A Finnish study of 68,800 patients found that hip fracture surgery is associated with a significant risk of surgical complications. Patients with osteoarthritis, Parkinson's disease, and rheumatic diseases are particularly at risk, with 4.6% experiencing complications within three months of surgery.
Researchers have discovered that macrophage activity is lowered when they sit in tissue between cells, even with pro-inflammatory stimuli present. This mechanism helps prevent unnecessary inflammatory responses in healthy tissues.
Researchers at Karolinska Institutet discovered high levels of antiphospholipid antibodies in patients who suffered a heart attack without any autoimmune conditions. The study involved 800 patients and found that 11% had elevated IgG antibody levels, which is associated with blood clots.
Researchers identified 42 locations associated with 99 genes of interest in a genome-wide association study of over 500,000 people. The analysis found genes related to connective tissue cells and pathways, which could inform the development of new treatments for diverticulitis.
Research suggests that non-steroidal anti-inflammatory drugs (NSAIDs) play a causal role in the cardiovascular risk of patients with osteoarthritis. A study found that over two-thirds of the increased cardiovascular risk associated with osteoarthritis is linked to NSAID use, particularly for congestive heart failure and ischemic heart ...
A study of over 1.23 million Medicare beneficiaries found a significant association between gout and increased risk of dementia in the elderly. Gout was linked to a 17-20% higher risk of dementia, with the risk being highest in older age groups, females, and people with comorbidities.